Data gathered: January 28
AI Stock Analysis - GoodRx (GDRX)
Analysis generated August 13, 2024. Powered by Chat GPT.
GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and a free-to-use website and mobile app which track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx’s approach is centered on improving access to healthcare through price transparency and consumer-focused digital solutions.
Stock Alerts - GoodRx (GDRX)
GoodRx | January 23 Business Outlook among employees is down by 4% over the last month. |
|
GoodRx | January 21 Price is up by 5.5% in the last 24h. |
|
GoodRx | January 13 Price is down by -6% in the last 24h. |
|
GoodRx | January 10 Price is up by 5.4% in the last 24h. |
Alternative Data for GoodRx
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 29 | Sign up | Sign up | Sign up | |
Sentiment | 75 | Sign up | Sign up | Sign up | |
Webpage traffic | 23,305,000 | Sign up | Sign up | Sign up | |
Employee Rating | 74 | Sign up | Sign up | Sign up | |
Google Trends | 92 | Sign up | Sign up | Sign up | |
Patents | 4 | Sign up | Sign up | Sign up | |
App Downloads | 5,952 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 13,452 | Sign up | Sign up | Sign up | |
Facebook Followers | 573,009 | Sign up | Sign up | Sign up | |
Instagram Followers | 55,080 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 1 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 5,539 | Sign up | Sign up | Sign up | |
Twitter Followers | 13,384 | Sign up | Sign up | Sign up | |
Twitter Mentions | 13 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 23,000 | Sign up | Sign up | Sign up | |
News Mentions | 1 | Sign up | Sign up | Sign up | |
Customer reviews | 88 | Sign up | Sign up | Sign up | |
Business Outlook | 48 | Sign up | Sign up | Sign up | |
Linkedin Employees | 1,133 | Sign up | Sign up | Sign up |
About GoodRx
GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States.
Price | $4.89 |
Target Price | Sign up |
Volume | 470,230 |
Market Cap | $1.89B |
Year Range | $4.15 - $9.05 |
Dividend Yield | 0% |
PE Ratio | 276.37 |
Analyst Rating | 50% buy |
Industry | Digital health |
In the news
NCPA Joins Class Action Suit Against GoodRx; CVS Caremark Corp.; Express Scripts, Inc.; MedImpact Healthcare Systems, Inc.; and Navitus Health Solutions, LLCJanuary 23 - Ncpa.org |
|
Scott Wagner appointed Co-Chair of GoodRx BoardJanuary 22 - Investing.com |
|
Scott Wagner Joins GoodRx Board of DirectorsJanuary 22 - Finnhub |
|
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.38 Consensus Target Price from AnalystsJanuary 19 - ETF Daily News |
|
GoodRx Holdings, Inc. CFO Transition: Romin Nabiey Appointed as Interim CFOJanuary 14 - ETF Daily News |
|
GoodRx (NASDAQ:GDRX) Shares Down 8.4% After Analyst DowngradeJanuary 14 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q3 '24 | 193M | 145M | 48M | 4M | -1.5M | 0.080 |
Q2 '24 | 201M | 150M | 51M | 6.7M | 43M | 0.080 |
Q1 '24 | 183M | 159M | 24M | -1M | 31M | 0.080 |
Q4 '23 | 182M | 177M | 5.1M | -26M | 34M | 0.080 |
Q3 '23 | 165M | 179M | -13M | -38M | 1.1M | 0.060 |
Insider Transactions View All
Nabiey Romin filed to sell 64,633 shares at $6.8. August 14 '24 |
Wagner Scott filed to buy 182,900 shares at $5.8. December 4 '23 |
Wagner Scott filed to buy 161,248 shares at $5.9. November 30 '23 |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
Teladoc HealthTDOC |
$10.52 3% | 52 |
|
Veeva SystemsVEEV |
$232.24 2.9% | 34 |
|
DoximityDOCS |
$57.13 3.2% | 79 |
|
Lifestance HealthLFST |
$8.17 2.1% | 67 |
|
AmwellAMWL |
$10.69 0.4% | 42 |
Read more about GoodRx (GDRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of GoodRx?
The Market Cap of GoodRx is $1.89B.
What is GoodRx's PE Ratio?
As of today, GoodRx's PE (Price to Earnings) ratio is 276.37.
What is the current stock price of GoodRx?
Currently, the price of one share of GoodRx stock is $4.89.
How can I analyze the GDRX stock price chart for investment decisions?
The GDRX stock price chart above provides a comprehensive visual representation of GoodRx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling GoodRx shares. Our platform offers an up-to-date GDRX stock price chart, along with technical data analysis and alternative data insights.
Does GDRX offer dividends to its shareholders?
As of our latest update, GoodRx (GDRX) does not offer dividends to its shareholders. Investors interested in GoodRx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of GoodRx?
Some of the similar stocks of GoodRx are Teladoc Health, Veeva Systems, Doximity, Lifestance Health, and Amwell.
.